Skip to main content
Clinical Trials/ACTRN12622000769785
ACTRN12622000769785
Completed
未知

Efficacy of the Vocational Intervention Program (VIP) in improving return to competitive employment following severe acquired brain injury (ABI): a controlled trial

Agency for Clinical Innovation (ACI)0 sites148 target enrollmentMay 30, 2022

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Agency for Clinical Innovation (ACI)
Enrollment
148
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

Research Questions: (1) Does the VIP improve return to work outcomes in people with sABI? (2) Does the effectiveness of the VIP differ according to whether it is delivered by general VR providers compared with a specialist VR unit? Background information: The VIP implementation study is a multi-centre, three-arm, non-randomized controlled trial – the VIP was delivered to participants by local VR providers partnered with local BIRP sites (VIP-VR), by a specialist VR unit as part of a direct service model (VIP-DS), or participants were treatment-as-usual controls that did not participate in the VIP (TAU). Competitive employment status (yes/no) was recorded at three timepoints – baseline (upon enrolment in VIP), upon completion of VIP, and 3 months following completion of VIP. Participant characteristics: A total of 149 people with sABI participated in the trial (VIP-VR, n=75; VIP-DS, n=33; TAU, n=40), of which 65 (60%) completed the VIP. The sample was overwhelmingly male (82%), predominantly young-to-middle aged, and most had attained high school education or higher. The VIP-VR and VIP-DS arms had a median of 1 year more education than TAU. The VIP-DS arm sustained their injuries more recently than the VIP-VR and TAU arms. Key results: The final model indicated that the VIP-VR (8%) and VIP-DS arms (6%) were less likely to be employed than TAU (38%) at baseline (p<.001). However, the VIP-VR (61%) and VIP-DS groups (77%) demonstrated significantly higher rates of return-to

Registry
who.int
Start Date
May 30, 2022
End Date
September 5, 2018
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Agency for Clinical Innovation (ACI)

Eligibility Criteria

Inclusion Criteria

  • A. Diagnosis (all participants)
  • Primary diagnosis of severe ABI:
  • oSevere to extremely severe TBI (PTA duration \> 24 hours); or
  • oSevere non\-traumatic (acquired) brain injury (e.g., resulting from an injury to the brain following a medical event such as stroke, brain infection, loss of oxygen from heart attack or drowning)
  • B. Currently engaged with the referring BIRP in a rehabilitation program (all participants)
  • C. Employment circumstances (VIP\-VR and VIP\-DS only)
  • Fast\-Track participants:
  • oEmployed at time of injury
  • oHas indicated a willingness to return to work (RTW) with pre\-injury employer
  • oPre\-injury employer able to provide a graded RTW program (Fast\-Track pathway)

Exclusion Criteria

  • All participants:
  • Requires significant support in the community that makes them unsuitable for mainstream work settings (e.g., 24 hours supervision/physical assistance)
  • Current alcohol or substance use disorder that could compromise program engagement
  • Additional criteria for New\-Track participants:
  • Does not have capacity or not amenable to attend a work training placement at least 8 hours per week and potential to work towards paid work at completion of the program (may utilise supported wage system, wage subsidies etc.)
  • Has a vocational goal and marketable skills suitable for obtaining new employment without VIP services
  • Requires formal qualifications/certificates to secure new employment

Outcomes

Primary Outcomes

Not specified

Similar Trials